Peptide Based Macrocycles: Selective Histone Deacetylase Inhibitors with Antiproliferative Activity
Authors: Rajak, H.; Singh, A.; K. Dewangan, P.; Patel, V.; K. Jain, D.; K. Tiwari, S.; Veerasamy, R.; C. Sharma, P.
Source: Current Medicinal Chemistry, Volume 20, Number 14, May 2013 , pp. 1887-1903(17)
Publisher: Bentham Science Publishers
Abstract:Histone deacetylase inhibitors (HDACi) have been enthusiastically investigated as a novel generation of chemotherapeutics for cancers usually called as epigenetic therapeutics. Histone deacetylases have been found to influence cellular function by catalyzing the removal of acetyl groups from ε-N-acetylated lysine residues of several protein substrates including histones, transcription factors, α-tubulin, and nuclear importers. Cyclic peptides represent the most structurally complicated and diverse class of histone deacetylase inhibitors. Each subtype of the Histone Deacetylase (HDAC) family perform a distinct role in the gene expression and cyclic peptides with their plentiful set of surface contacts, zinc binding group and macrocyclic cap, can target enzyme precisely through adequate modulation of the amino acid configurational and structural assortment. The present article summarizes current status of different peptide based macrocyclic compounds being developed as HDACi for the treatment of cancer.
Keywords: Anticancer agents; HDAC; apoptosis; cyclic tetrapeptides; depsipeptides; extrinsic pathway; histone acetylation; histone deacetylase inhibitors; histone deacetylation; intrinsic pathway; macrocycles
Document Type: Research Article
Publication date: May 2013
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.